Behind the Scenes of CVS Health's Latest Options Trends
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
JD Supra1h
Antitrust and Competition Life Sciences Year in Review 2024
The last year (and particularly the last few months) of the Biden Administration brought a flurry of activity from the Federal Trade Commission ...
Weekly Roundup: 15 Health Press Releases You Need to See
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
CVS Health put volume heavy and directionally bearish
Bearish flow noted in CVS Health (CVS) with 13,937 puts trading, or 2x expected. Most active are Mar-25 60 puts and Feb-25 63 puts, with total ...
Foes in FTC Insulin-Price Case Fire Off Subpoenas in Every Direction, From McDonald’s to Defense Department
After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...
DOJ Investigates UnitedHealth, Probe Accuses Of Inflating Medicare Diagnoses
The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher ...
Oklahoma doesn't have enough pharmacists. That's a public health issue | Opinion
The pharmacist shortage in Oklahoma is not just an inconvenience, it's a growing public health issue that new legislation ...